| Literature DB >> 31888208 |
Xue Feng1, Suisui Jiang1, Fan Zhang1, Runfang Wang1, Yuanhui Zhao1, Mingyong Zeng1.
Abstract
Siderophores are iron chelators with low molecular weight secreted by microorganisms. Siderophores have the potential to become natural iron fortifiers. To explore the feasibility of the application of Synechococcus sp. PCC7002-derived siderophores as iron fortifiers, Synechococcus sp. PCC7002, as a carrier, was fermented to produce siderophores. The absorption mechanism and anemia intervention effect of siderophores-chelated iron (SCI) were studied through the polarized Caco-2 Cell monolayers and the rat model of iron-deficiency anemia, respectively. The results indicated that siderophores (from Synechococcus sp. PCC7002) had an enhancing effect on iron absorption in polarized Caco-2 cell monolayers. The main absorption site of SCI was duodenum with pH 5.5, and the absorption methods included endocytosis and DMT1, with endocytosis being dominant. The effect of sodium phytate on SCI was less than that of ferrous sulfate. Therefore, SCI could resist inhibitory iron absorption factors in polarized Caco-2 cell monolayers. SCI showed significantly higher relative bioavailability (133.58 ± 15.42%) than ferrous sulfate (100 ± 14.84%) and ferric citrate (66.34 ± 8.715%) in the rat model. Food intake, hemoglobin concentration, and hematocrit and serum iron concentration of rats improved significantly after Fe-repletion. Overall, this study indicated that siderophores derived from Synechococcus sp. PCC7002 could be an effective and feasible iron nutritive fortifier.Entities:
Keywords: Caco-2 cell; Synechococcus sp. PCC 7002; anemia intervention; iron-deficiency anemia; siderophores
Mesh:
Substances:
Year: 2019 PMID: 31888208 PMCID: PMC6950231 DOI: 10.3390/md17120709
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1(a) Iron intake content of SFE-Fe in polarized Caco-2 cell monolayers with different pH. (b) Iron uptake content of SFE-Fe, SCE-Fe, and SFP-Fe in polarized Caco-2 cell monolayers. Values are expressed as means ± standard deviations (n = 3).
Figure 2(a) Iron intake content of SFE-Fe in polarized Caco-2 cell monolayers when BPDS adding. (b) The ferrous concentrations of different sample when incubated for 2 h in polarized Caco-2 cell monolayers (Pad: sodium phytate). Values are expressed as means ± standard deviations (n = 3). Bars with different letters are significantly different (p < 0.05).
Figure 3(a) The effect of sodium phytate on iron uptake of SFE-Fe in polarized Caco-2 cell monolayers (Pad: sodium phytate;). (b) Iron uptake content of SFE-Fe with different concentrations in polarized Caco-2 cell monolayers. Values are expressed as means ± standard deviations (n = 3).
The weight changes and diet intakes of rates at the end of iron repletion period. Values are expressed as means ± standard deviations (n = 8). Different lowercase letters in the same column indicate significant differences between groups and intragroup, respectively; (p < 0.05).
| Group | Iron Repletion | ||||
|---|---|---|---|---|---|
| Control | Fe-Deficient | FeSO4 | SFC-Fe | Ferric Citrate | |
| N | 8 | 8 | 8 | 8 | 8 |
| Diet iron (mg/Kg) | 36.7 ± 0.12 | 13.08 ± 1.34 | 29.11 ± 0.9 | 29.56 ± 1.3 | 33.32 ± 0.92 |
| Diet intake (g) | 348.64 | 247.36 | 286.77 | 316.01 | 259.78 |
| Initial BW (g) | 254.5 ± 25.66 a | 170.13 ± 28.74 b | 170.33 ± 31.76 b | 171.25 ± 18.99 b | 170.13 ± 19.08 b |
| Final BW (g) | 356.5 ± 32.93 a | 205.38 ± 31.15 b | 245.67 ± 45.46 c | 292.1 ± 34.91 d | 231.63 ± 26.94 c |
| BW changes (g) | 102 ± 9.77 a | 30.25 ± 12.29 b | 75.33 ± 14.83 c | 120.75 ± 17.87 d | 61.5 ± 9.57 e |
BW: body weight.
The blood indexes of rats at the end of iron repletion period. Values are expressed as means ± standard deviations (n = 8). Different lowercase letters in the same column indicate significant between groups and intragroup differences, respectively; (p < 0.05).
| Group | Iron Repletion | ||||
|---|---|---|---|---|---|
| Control | Fe-Deficient | FeSO4 | SFC-Fe | Ferric Citrate | |
| Initial Hb (g/L) | 162.25 ± 20.50 a | 74.5 ± 13.48 b | 73.11 ± 14.24 b | 72.75 ± 12.73 b | 71.75 ± 15.95 b |
| Final Hb (g/L) | 166.25 ± 22.55 a | 71.5 ± 20.97 b | 132.44 ± 16.99 c | 145.75 ± 16.51 c | 113 ± 21.82 d |
| Hb change (g/L) | 4 ± 3.74 a | −3 ± 9.14 a | 59.33 ± 5.27 b | 73 ± 5.89 c | 41.25 ± 7.14 d |
| Initial Hct(%) | 45.65 ± 4.09 a | 15.9 ± 4.43 b | 14 ± 3.32 b | 14.48 ± 3.55 b | 15.35 ± 5.22 b |
| Final Hct (%) | 48.13 ± 6.88 a | 10.5 ± 5.55 b | 36.78 ± 4.27 c | 39.25 ± 9.56 c | 28.15 ± 9.61 d |
| Initial serum iron (μg/g) | 35.46 ± 5.14 a | 10.37 ± 2.21 b | 10.47 ± 3.57 b | 10.6 ± 2.74 b | 10.6 ± 1.99 b |
| Final serum iron (μg/g) | 35.57 ± 7.62 a | 8.72 ± 3.32 b | 28.59 ± 10.76 c | 31.69 ± 8.85 c | 22.26 ± 6.11 d |
Hb: hemoglobin; Hct: hematocrit.
Figure 4(a) Liver iron concentrations of different groups at the end of iron repletion period (FC-de: Fe-deficient, FC: ferric citrate). (b) Relative biological values of iron of different iron supplements. Values are expressed as means ± standard deviations (n = 8). Bars with different letters are significantly different (p < 0.05).
Figure 5Synechococcus sp. PCC 7002 cultivation in 10 L glass photobioreactors.
Figure 6Schematic representation of the plan of animal experiment (the variable n represents the animal number).